WiseGuyReports.com adds “LVAD Global Market 2016 to 2020” to its research database.
This market research report includes a detailed segmentation of the global LVAD market by application (BTT therapy, BTD therapy, destination therapy, and BTR therapy). It also outlines the market shares of key regions such as the Americas, APAC, and EMEA. The key vendors analyzed in this report are Abiomed, HeartWare, and St. Jude Medical.
Market overview of the left ventricular assist device (LVAD) market
Technavio’s market research analyst predicts the global LVAD market to account for a CAGR of over 13% during the forecast period. Increasing incidences of cardiac disorders and hypertension is the primary driver for the market growth. The market growth is induced by the incidence of heart failure and arrhythmia coupled with increase market penetration and development of advanced LVAD. For instance, over 9 million deaths occur each year, out of which more than 16% can be attributed to high blood pressure. This includes 51% of deaths because of stroke and the rest because of cardiac disorders. LVADs are sighted to become a great success in contributing to support individuals globally and enhance their quality of life.
Some of the LVADs which are under development may be more appealing to patients. For instance, fully implantable LVADs, which are currently under investigation, will eliminate the need to carry portable drivers required to charge current-generation LVADs for patients. These wireless LVADs will increase the quality of life, and therefore, minimize uncertainties among patients when considering LVAD implantation as a treatment option.
Complete report in Detailed @ https://www.wiseguyreports.com/reports/global-lvad-market-2016-2020
Application segmentation and analysis of the LVAD market
- Bridge to transplant (BTT) therapy
- Bridge to destination (BTD) therapy
- Destination therapy
- Bridge to recovery (BTR) therapy
The destination therapy occupied the largest share in the LVAD market with a market share of more than 47% during 2015. This process involves the use of ventricular assist devices (VADs) in patients that have irreversible heart failure but are not candidates for cardiac transplantation because of factors such as advanced age, smoking, and cancer.
Order a Purchase Report Copy @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=366380
Geographical segmentation and analysis of the LVAD market
The adoption of MI devices for heart surgeries over open-heart surgeries and the availability of reimbursements by Medicare have led to the growth of the LVAD market in the Americas, leading to its dominance during 2015. Vendors are increasing offering products through clinical trials, which is also expected to have a significant impact on the growth of the market in this region.
Competitive landscape and key vendors
As the global LVAD market presents tremendous opportunities for growth, many vendors are adopting numerous strategies to remain competitive. Vendors are focusing on promising product pipelines and strategic alliances with other vendors to expand their geographical presence and improve technology.
The leading vendors in the market are -
- St. Jude Medical
Other prominent vendors in the market include Berlin Heart, Cardiac Assist, Jarvik Heart, ReliantHeart, Terumo Heart, and Sunshine Heart.
Enquiry before buying https://www.wiseguyreports.com/enquiry/global-lvad-market-2016-2020
P: +44 208 133 9349
M: +1 646 845 9349